In 2016, The Babich Family Foundation, through their RUNX1 Research Program, partnered with Alex’s Lemonade Stand Foundation to accelerate research of FPD/AML due to monoallelic germline RUNX1 mutations. We are thrilled to offer the grant for a third year! The ultimate goal is to develop effective therapies to prevent the onset of acute myeloid leukemia (AML) for families affected by familial platelet disorder.
The Familial RUNX1 Grant is seed funding for studies such as understanding the biological basis for disease progression, developing models and identifying strategies leading to the development of therapies for preventing the transition from pre-leukemia to leukemia. The grant is open to adult and childhood cancer investigators at U.S. or foreign institutions. The grant is $250,000 over two years.
“We are grateful to Alex’s Lemonade Stand Foundation for their continued partnership with this endeavor,” said Timothy Babich, Director of The RUNX1 Research Program. “The grant program has energized the field, bringing new ideas to the table that have the potential to make a great difference in the lives of those of us who suffer with this disorder, as well as the larger blood cancer universe.”
Letters of Intent will be accepted until July 2, 2018. Guidelines and information.